Kaneka Pharma America, LLC

Distributor of life science systems

Based in CA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $1.6M in lobbying spend across 35 quarterly filings, Kaneka Pharma America, LLC is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.

$1.6M
Total Spend
8
Years Active
1
Firms Hired
8
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$320K
2019$300K
2020$220K
2021$190K
2022$140K
2023$120K
2024$120K
2025$140K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

King & Spalding LLP

Lobbyists

Allison KassirPreeya PintoDavid FarberWilliam ClarksonJeannine BenderMichael AndrewsAlexander ("ander") CrenshawScott Dziengelski

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

  • •Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Kaiser Foundation Health Plan INC
$31.5M total spend
Jazz Pharmaceuticals, INC.
$11.5M total spend
Biomarin Pharmaceutical INC.
$9.6M total spend
Acadia Pharmaceuticals
$7.3M total spend
Sarepta Therapeutics, INC.
$6.3M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.